BNTX
BNTX clinical trials: BioNTech SE
Every trial on ClinicalTrials.gov where BioNTech SE is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 120
- Trials linked
- 85
- As lead sponsor
- 35
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
BNTX on the catalyst calendar · BNTX registry changes
- Primary completion Mar 2028Sponsor estimatePhase 1/Phase 2NCT07070232A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in...BioNTech SE · Advanced Solid TumorRecruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 12, 2027Sponsor estimatePhase 3NCT07798648A Study of COVID-19 Vaccine(s) in Children and AdultsBioNTech SE · COVID-19 VaccinesActive, not recruitingBNTXLeadPFECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2031Sponsor estimatePhase 3NCT07365995A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerBioNTech SE · Metastatic Castration-resistant Prostate CancerRecruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2028Sponsor estimatePhase 1/Phase 2NCT07111520A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People...BioNTech SE · Non-small Cell Lung CancerRecruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2029Sponsor estimatePhase 1/Phase 2NCT06827236A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another...BioNTech SE · Locally Advanced Breast CancerRecruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2028Sponsor estimatePhase 3NCT06340568A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerBioNTech SE · Endometrial CancerRecruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2029Sponsor estimatePhase 2/Phase 3NCT04534205A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus...BioNTech SE · Unresectable Head and Neck Squamous Cell CarcinomaActive, not recruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2027Sponsor estimatePhase 2NCT06449209Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With...BioNTech SE · Extensive-stage Small-cell Lung CancerActive, not recruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2029Sponsor estimatePhase 3NCT07173751ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerBioNTech SE · Breast NeoplasmsRecruitingBNTXLeadBMYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2029Sponsor estimatePhase 2/Phase 3NCT06712316Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer...BioNTech SE · Non-small Cell Lung CancerRecruitingBNTXLeadBMYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2028Sponsor estimatePhase 2NCT07297212A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent...BioNTech SE · Recurrent GlioblastomaRecruitingBNTXLeadBMYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2026Sponsor estimatePhase 1NCT05432583A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune...BioNTech SE · Genital Herpes Simplex Type 2Active, not recruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2029Sponsor estimatePhase 1NCT07893054A First-in-human Clinical Trial to Test if the Investigational Drug BNT3219 is Safe and Potentially Beneficial for People With Advanced...BioNTech SE · Advanced Solid TumorsNot yet recruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2029Sponsor estimatePhase 1/Phase 2NCT07886684A Clinical Trial to Test if the Investigational Drug BNT3210 is Safe and Potentially Beneficial for People With Advanced Solid Tumors...BioNTech SE · Advanced Solid TumorsNot yet recruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2030Sponsor estimatePhase 1/Phase 2NCT07186842A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors...BioNTech SE · Advanced Solid CancersRecruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2028Sponsor estimatePhase 1NCT07698600A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIVBioNTech SE · HIV -1 InfectionRecruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 22, 2026ActualPhase 3NCT07300839A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of AgeBioNTech SE · COVID-19CompletedBNTXLeadPFECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2029Sponsor estimatePhase 3NCT06712355Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung...BioNTech SE · Extensive-stage Small-cell Lung CancerRecruitingBNTXLeadBMYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2026Sponsor estimatePhase 2NCT04486378A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II...BioNTech SE · Colorectal Cancer Stage IIActive, not recruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 18, 2026ActualPhase 1NCT06150183Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid TumorsBioNTech SE · Advanced Malignant Solid TumorActive, not recruitingBNTXLeadGMABCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2031Sponsor estimatePhase 1/Phase 2NCT06750185Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid TumorsBioNTech SE · Advanced Solid TumorRecruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2026Sponsor estimatePhase 1NCT07392372A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIVBioNTech SE · HIV -1 InfectionRecruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2028Sponsor estimatePhase 1/Phase 2NCT06892548A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients...BioNTech SE · Advanced Lung CancerRecruitingBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 25, 2025ActualPhase 1/Phase 2NCT05988203A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox VaccinesBioNTech SE · MonkeypoxCompletedBNTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 15, 2025ActualPhase 1/Phase 2NCT06683352A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy PeopleBioNTech SE · Influenza,HumanCompletedBNTXLeadPFECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 95 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner